```html

Ankylostomiasis (Hookworm Infection) – Comprehensive Medical Guide

Overview

Ankylostomiasis is a parasitic intestinal infection caused by hookworms of the genera Necator (most commonly N. americanus) and Ancylostoma (A. duodenale and A. ceylanicum). The adult worms attach to the mucosa of the small intestine, feed on host blood, and can cause chronic anemia and protein loss.

The disease is most prevalent in tropical and subtropical regions where warm, moist soil facilitates the development of infective larvae. An estimated 500 million to 740 million people worldwide are infected, with the highest burden in sub‑Saharan Africa, Southeast Asia, and parts of South America [WHO, 2022].

Although anyone can become infected, the greatest risk falls on children, pregnant women, and people living in poverty‑linked conditions such as inadequate sanitation, open defecation, and barefoot walking.

Symptoms

Symptoms vary according to the intensity of infection (light vs. heavy) and the stage of disease (early skin invasion vs. chronic intestinal phase).

• Skin irritation (“ground itch”) – an itchy, erythematous rash at the site where larvae penetrate the skin, usually the feet or lower legs.
• Cough and mild respiratory symptoms – larvae travel via the bloodstream to the lungs; patients may experience a dry cough, wheezing, or shortness of breath (Löffler‑type pulmonary infiltrates).
• Gastro‑intestinal symptoms
  • Abdominal pain or cramps
  • Nausea or loss of appetite
  • Diarrhea (occasionally bloody in severe cases)
• Iron‑deficiency anemia – chronic blood loss can lead to fatigue, pallor, shortness of breath on exertion, and reduced exercise tolerance.
• Protein‑energy malnutrition – especially in children, resulting in growth retardation, stunted height, and cognitive delays.
• Weight loss – due to malabsorption and chronic inflammation.
• Peripheral edema – rare, secondary to severe hypo‑albuminemia.

In light infections, many individuals remain asymptomatic, and the disease may only be discovered incidentally on stool examination.

Causes and Risk Factors

Life Cycle Overview

1. Eggs are passed in feces and hatch in warm, moist soil (temperature 20‑30 °C).
2. Free‑living larvae (rhabditiform) develop into infective filariform larvae within 5‑10 days.
3. Skin penetration – larvae penetrate bare skin, usually the feet.
4. Migration – larvae travel via the bloodstream to the lungs, ascend the trachea, are swallowed, and reach the small intestine.
5. Adult worms attach to the intestinal villi, feed on blood, and mature into egg‑producing females (up to 30 mm long for N. americanus).
6. Eggs are shed in feces, completing the cycle.

Key Risk Factors

• Living in or traveling to endemic areas with warm, humid climates.
• Poor sanitation – open defecation or use of human feces as fertilizer.
• Walking barefoot or wearing inadequate footwear.
• Children playing in contaminated soil.
• Poor nutrition – iron or protein deficiency can exacerbate disease severity.
• Pregnancy – hormonal changes may increase susceptibility.

Diagnosis

Clinical Suspicion

Physicians consider ankylostomiasis when patients present with anemia, gastrointestinal symptoms, or a history of exposure (e.g., walking barefoot in endemic regions). However, laboratory confirmation is essential.

Laboratory Tests

• Stool microscopy (direct smear, concentration techniques, or Kato‑Katz) – detection of characteristic oval, thin‑shelled eggs (approximately 60‑75 µm × 40‑45 µm). Multiple specimens (ideally three on separate days) improve sensitivity.
• Fecal antigen detection – enzyme‑linked immunosorbent assay (ELISA) kits are more sensitive, especially in low‑intensity infections.
• Serology – rarely used because antibodies persist after cure.
• Complete blood count (CBC) – often shows microcytic, hypochromic anemia; eosinophilia may be present during the pulmonary migration phase.
• Iron studies – ferritin, serum iron, total iron‑binding capacity to assess iron‑deficiency.

Imaging (Rarely Needed)

Chest radiography can reveal transient infiltrates during the pulmonary migration phase, but this finding is non‑specific.

Treatment Options

First‑Line Anthelmintics

Drug	Typical Dose (Adults)	Duration	Notes
Albendazole	400 mg orally, single dose	1 day	Most widely used; >95% cure rate for N. americanus and A. duodenale [CDC, 2023].
Mebendazole	100 mg orally, twice daily for 3 days	3 days	Alternative when albendazole unavailable; slightly lower efficacy.
Ivermectin	200 µg/kg orally, single dose	1 day	Effective for A. ceylanicum and mixed infections.

Adjunctive Therapy

• Iron supplementation – oral ferrous sulfate (325 mg elemental iron) 1–2 times daily until hemoglobin normalizes.
• Protein‑rich diet – to correct hypo‑albuminemia.
• Vitamin A – especially in children, to support mucosal integrity.

Follow‑Up

Repeat stool examination 2–4 weeks after treatment to confirm eradication. Reinfection is common in endemic settings; repeat mass‑drug administration (MDA) programs may be recommended by public health authorities.

Living with Ankylostomiasis

Daily Management Tips

• Take prescribed anthelmintic medication exactly as directed; do not skip doses.
• Consume iron‑rich foods (red meat, beans, lentils, dark leafy greens) and pair with vitamin C to enhance absorption.
• Stay hydrated; chronic diarrhea can worsen dehydration and electrolyte imbalance.
• Wear closed shoes or sandals at all times, especially outdoors.
• Maintain good personal hygiene – wash hands with soap after using the toilet and before handling food.
• If you have children, ensure they wash hands and feet before school and after playing outside.

Monitoring

Track symptoms such as fatigue, shortness of breath, or recurrent abdominal pain. Keep a record of hemoglobin and ferritin levels; schedule routine blood tests every 3‑6 months if you remain in an endemic area.

Prevention

• Wear protective footwear at all times when walking on soil or sand.
• Improve sanitation – use latrines, avoid open defecation, and promote community-led total sanitation (CLTS) programs.
• Soil decontamination – in agricultural settings, compost human feces for at least 6 months before use as fertilizer.
• Health education – school‑based programs teaching children about safe play and hygiene.
• Periodic deworming – WHO recommends annual or biannual mass‑drug administration of albendazole (400 mg) to at‑risk populations, especially school‑age children.
• Pregnancy considerations – treat infected pregnant women after the first trimester to reduce maternal anemia and improve fetal outcomes.

Complications

If left untreated or if reinfection is frequent, chronic hookworm disease can lead to:

• Severe iron‑deficiency anemia → cardiac strain, heart failure in extreme cases.
• Protein‑energy malnutrition → stunted growth, impaired cognitive development in children.
• Hypo‑albuminemia → peripheral edema and ascites.
• Secondary bacterial infections of skin lesions.
• In pregnancy, increased risk of low birth weight, preterm delivery, and maternal mortality.

While hookworms rarely cause intestinal obstruction or perforation, heavy infestations can exacerbate existing gastrointestinal diseases (e.g., inflammatory bowel disease).

When to Seek Emergency Care

References

1. World Health Organization. Soil‑transmitted helminth infections: Global prevalence and burden. WHO, 2022.
2. Centers for Disease Control and Prevention. Hookworm (Ancylostoma duodenale and Necator americanus) – Parasites – DPDx. Updated 2023.
3. Mayo Clinic. Hookworm infection. Accessed May 2026.
4. Cleveland Clinic. Hookworm disease: Symptoms, causes, treatments. 2024.
5. National Institutes of Health. Albendazole: Drug information. 2023.

```